TMCnet News

Research and Markets: Global Human Papillomavirus (HPV) Associated Cancer Therapeutics Pipeline Review 2015 - 25 Companies & 33 Drug Profiles
[March 04, 2015]

Research and Markets: Global Human Papillomavirus (HPV) Associated Cancer Therapeutics Pipeline Review 2015 - 25 Companies & 33 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/f3j427/human) has announced the addition of the "Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Human Papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human papillomavirus (HPV) Associated Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics evelopment



  • 3SBio Inc.
  • Abivax
  • Admedus Ltd
  • Antigen Express, Inc.
  • Bionor Pharma ASA
  • Cancer Therapeutics CRC Pty Ltd
  • Etubics Corporation
  • EyeGene, Inc.
  • Formune S.L.
  • Genexine, Inc.
  • iBio, Inc.
  • Inovio Pharmaceuticals, Inc.
  • MedImmune, LLC
  • Merck & Co., Inc.
  • Novartis AG
  • Onconova Therapeutics, Inc.
  • Prima BioMed Ltd.
  • Profectus BioSciences, Inc.
  • Redbiotec AG
  • Sirnaomics, Inc.
  • Theravectys S.A.
  • Transgene SA
  • Vaccibody AS
  • Virometix AG
  • ViroStatics, srl

Drug Profiles

  • ABX-318
  • AEH-10p
  • alpelisib
  • Antibodies to Target (News - Alert) E6 for HPV Associated Cancer
  • Antibodies to Target E7 for HPV Associated Cancer
  • Cell Therapy to Target HPV-16 E6 Protein for Papillomavirus Associated Cancers
  • durvalumab + tremelimumab
  • EDA-HPVE7
  • EG-HPV
  • Gene Therapy for Papillomavirus Associated Cervical Carcinoma
  • GX-188E
  • HPV Vaccine
  • Human Papillomavirus (7-valent) vaccine
  • Human Papillomavirus (9-valent) vaccine
  • Human Papillomavirus [Serotype 16] vaccine
  • Human Papillomavirus vaccine [types 6, 11, 16, 18] biosimilar
  • INO-3106
  • INO-3112
  • Peptide to Inhibit HPV E6 Protein for HPV Associated Cancer
  • RBT-201
  • rigosertib sodium
  • Small Molecule to Inhibit CDK9 for HPV Associated Cancers and Warts
  • Small Molecules to Inhibit Ubiquitin E3 Ligase E6AP for Cancer
  • SSS-08
  • STP-909
  • STP-911
  • TG-4001
  • Vacc-HPV
  • Vaccine for HPV Associated Head and Neck Cancer
  • Vaccine for HPV Associated Skin Cancer

For more information visit http://www.researchandmarkets.com/research/f3j427/human



[ Back To TMCnet.com's Homepage ]